Ignite Creation Date:
2025-12-24 @ 1:06 PM
Ignite Modification Date:
2026-01-31 @ 4:11 AM
Study NCT ID:
NCT00295061
Status:
COMPLETED
Last Update Posted:
2014-09-09
First Post:
2006-02-20
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Comparison of Pharmacokinetic, Safety, Tolerability of Alpha-1 MP and Prolastin In Alpha1-antitrypsin Deficient Adults
Sponsor:
Grifols Therapeutics LLC
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
11816
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
None
Responsible Party Affiliation:
Old Name:
Gerald Klein, MD, Chief Medical Officer, Vice President of Medical and Clinical Affairs
Old Organization:
Talecris Biotherapeutics, Inc.